Stockscreener 앱 받기
2.40
5.26%
0.12
시간 외 거래:
2.40
전일 마감가:
$2.28
열려 있는:
$2.28
하루 거래량:
745.12K
Relative Volume:
0.65
시가총액:
$136.47M
수익:
-
순이익/손실:
$-82.44M
주가수익비율:
-1.2766
EPS:
-1.88
순현금흐름:
$-66.75M
1주 성능:
-7.34%
1개월 성능:
-4.00%
6개월 성능:
-2.44%
1년 성능:
-50.46%
1일 변동 폭
$2.2521
$2.425
1주일 범위
$2.22
$2.87
52주 변동 폭
$1.195
$6.75
Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
명칭
Black Diamond Therapeutics Inc
전화
617-417-5868
주소
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
BDTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BDTX
Black Diamond Therapeutics Inc
|
2.40 | 152.96M | 0 | -82.44M | -66.75M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-01 | 재개 | Raymond James | Outperform |
| 2024-07-31 | 개시 | Raymond James | Outperform |
| 2023-07-14 | 개시 | Piper Sandler | Overweight |
| 2023-06-30 | 업그레이드 | Stifel | Hold → Buy |
| 2023-06-28 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-06-27 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2022-03-29 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2022-03-22 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2021-09-30 | 개시 | Stifel | Hold |
| 2021-01-07 | 개시 | Wedbush | Outperform |
| 2020-11-24 | 개시 | Berenberg | Buy |
| 2020-05-04 | 개시 | H.C. Wainwright | Buy |
| 2020-02-24 | 개시 | Canaccord Genuity | Buy |
| 2020-02-24 | 개시 | Cowen | Outperform |
| 2020-02-24 | 개시 | JP Morgan | Overweight |
| 2020-02-24 | 개시 | Jefferies | Buy |
모두보기
Black Diamond Therapeutics Inc 주식(BDTX)의 최신 뉴스
Black Diamond Therapeutics Reports Strong Financial Turnaround - TipRanks
News impact scoring models applied to Black Diamond Therapeutics Inc.Free AI Based High Gain Watchlist Scanner - Newser
Black Diamond Therapeutics Slims Losses And Stays Flush With Cash - Finimize
Black Diamond (BDTX) Q2 Loss Narrows 47% - AOL.com
Black Diamond Therapeutics: Navigating Turbulent Waters with Strategic Precision - AInvest
Black Diamond Therapeutics Cuts Losses And Eyes Silevertinib Growth - Finimize
Black Diamond: Q2 Earnings Snapshot - The Washington Post
Black Diamond Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Black Diamond Therapeutics Q2 Loss Narrower Than ExpectedNews and Statistics - IndexBox
Black Diamond Therapeutics Q2 eps $-0.19 - MarketScreener
Black Diamond (BDTX) Q2 Loss Narrows 47% - The Motley Fool
Black Diamond Therapeutics Completes Enrollment in Phase 2 Trial of Silevertinib for Non-Classical EGFRm NSCLC - Quiver Quantitative
Black Diamond Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Black Diamond Therapeutics, Inc. SEC 10-Q Report - TradingView
What makes Black Diamond Therapeutics Inc. stock price move sharplyFundamental + Technical Combined Watchlist - Newser
Is Black Diamond Therapeutics Inc. stock ready for a breakoutRisk-Managed Strategy Based on Price Analysis - Newser
Why Black Diamond Therapeutics Inc. stock attracts strong analyst attentionFree Investment Playbook for Growing Markets - Newser
Price action breakdown for Black Diamond Therapeutics Inc.Daily Profit Watch With Forecast Confidence - Newser
Chart based analysis of Black Diamond Therapeutics Inc. trendsFree Capital Efficiency Optimized Stock Alerts - Newser
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Given Average Rating of “Buy” by Brokerages - Defense World
Is Black Diamond Therapeutics Inc. a Top Dividend Stock to Watch in 2025Short-Term Market Movement Forecast Report - Newser
Top Risks to Consider Before Buying Black Diamond Therapeutics Inc. StockWeekly Chart Watchlist with Trade Guidance - Newser
Using portfolio simulators with Black Diamond Therapeutics Inc. includedReal-Time Entry Forecast with Accuracy Metrics - Newser
Historical volatility pattern of Black Diamond Therapeutics Inc. visualizedFree Trade Setups With AI Powered Filters - Newser
Has Black Diamond Therapeutics Inc. formed a bullish divergenceFree AI Screening for Swing Trade Picks - Newser
Will Black Diamond Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsDaily Upside Movement Prediction With Data - Newser
Competitive Positioning of Black Diamond Therapeutics Inc.: Is It Leading or LaggingDaily Swing Candidate Analysis with Chart Patterns - Newser
What institutional investors are buying Black Diamond Therapeutics Inc. stockMaximize your portfolio’s earning potential - Jammu Links News
Is Black Diamond Therapeutics Inc. stock overvalued or undervaluedExponential return rates - Jammu Links News
What is Black Diamond Therapeutics Inc. company’s growth strategySuperior investment outcomes - Jammu Links News
What are Black Diamond Therapeutics Inc. company’s key revenue driversCapitalize on emerging investment opportunities - Jammu Links News
What analysts say about Black Diamond Therapeutics Inc. stockHarness the power of proven investment plans - Jammu Links News
Automated trading signals detected on Black Diamond Therapeutics Inc.Monthly Trade Result and Signal Summary - Newser
How volatile is Black Diamond Therapeutics Inc. stock compared to the marketFind the best stocks for sustainable growth - Jammu Links News
How strong is Black Diamond Therapeutics Inc. company’s balance sheetAchieve rapid portfolio appreciation today - Jammu Links News
Black Diamond Therapeutics Inc. Stock Analysis and ForecastInvest smarter with data-backed trading alerts - Jammu Links News
What are the technical indicators suggesting about Black Diamond Therapeutics Inc.Consistent high-yield stocks - Jammu Links News
What are the latest earnings results for Black Diamond Therapeutics Inc.Build a diversified portfolio for stability - Jammu Links News
Published on: 2025-08-03 01:51:06 - Jammu Links News
What is the risk reward ratio of investing in Black Diamond Therapeutics Inc. stockBest Dividend Updates For Beginners - Jammu Links News
Black Diamond Therapeutics Inc (BDTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):